Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
crispr
editas medicine
abbvie
allergan
alzheimer's disease
bill gates
bio
biotech
boston
boston blog main
boston top stories
clinical trials
cynthia collins
deals
gene editing
google ventures
government
health
initial public offering
leber congenital amaurosis type 10
life sciences
michelle robertson
national blog main
parkinson's disease
rare diseases
san francisco blog main
stock market
tc
voyager therapeutics
What
biotech
2
×
editas
2
×
editing
gene
2
×
abbvie
alliance
believe
built
company’s
concerns
crispr
debut
dispute
drop
drops
exits
experimental
far
genetic
hours
ipo’s
legally
medicines
nearly
outfit
pact
partnership
patent
percent
plummeted
pruning
public
read
research
returning
rights
shares
shortly
skyrocketing
stock
Language
unset
Current search:
gene
×
biotech
×
editas
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@techcrunch.com
8 years ago
Editas biotech stock drops by 26% over CRISPR patent dispute
